Sheri Krams
Publication Details
-
Epstein-Barr virus, rapamycin, and host immune responses.
Curr Opin Organ Transplant. 2008; (6): 563-8
To summarize recent advances that contribute to our understanding of the pathobiology of Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disease (PTLD), the host immune response to virally infected B cells, and the molecular basis for the effects of mammalian target of rapamycin inhibitors on EBV+ B-cell lymphomas.
Help